PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'German Center for Infection Research (DZIF), Partner Site, Munich, Germany.\', \'Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität (LMU) Munich, Germany.\', \'Klinikum Landsberg am Lech, Internal Medicine, Landsberg am Lech, Germany.\', \'Bundeswehr Institute of Microbiology, 80937 Munich, Germany.\', \'Bavarian Health and Food Safety Authority (LGL), Oberschleissheim, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.2807/1560-7917.ES.2021.26.30.2100673
?:doi
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 34328074
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B.1.351) variant, Bavaria, Germany, February to March 2021.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all